Glaxosmithkline | GSK - Ebitda

Precio De Mercado
52.41
Cambio Diario
-6.71 -11.35%
Mensual
-11.56%
Anual
35.25%
Q2 Expectativa
53.52




Ebitda Cambio Fecha
AbbVie USD 5.37B 1.85B 2025-12
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Aurora Cannabis CAD 18.48M 3.11M 2025-12
Bausch Health Companies USD 837M 94M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Canopy Growth CAD -2.87M 19.49M 2025-12
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Drreddys Laboratories INR 21.59B 1.49B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Glaxosmithkline GBP 4.75B 1.52B 2025-09
J&J USD 7.19B 2.32B 2025-12
Merck USD 6.3B 2.09B 2025-12
Novartis USD 5.3B 530M 2026-03
Pacira USD 38.71M 10.65M 2025-12
Perrigo USD 258.8M 37.3M 2025-09
Pfizer USD 6.08B 351M 2025-09
Phibro Animal Health USD 68.1M 6.2M 2025-12
Prestige Brands USD 90.82M 3.99M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
Supernus Pharmaceuticals USD 48.5M 6.6M 2025-12
Takeda JPY 448.13B 173.98B 2025-12
Teva Pharmaceutical Industries USD 1.06B 582M 2026-03
Zoetis USD 1.04B 87M 2025-09